# Once Daily Immunosuppression Regimen

> **NCT03555448** · PHASE4 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 51 (actual)

## Conditions studied

- Kidney Transplant; Complications

## Interventions

- **DRUG:** Once daily immunosuppression regimen
- **DRUG:** Twice daily immunosuppression regimen

## Key facts

- **NCT ID:** NCT03555448
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-06-04
- **Primary completion:** 2023-11-10
- **Final completion:** 2023-11-10
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** poor recruitment during pandemic and after
- **Last updated:** 2025-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03555448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03555448, "Once Daily Immunosuppression Regimen". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03555448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*